Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7CJL

Metallo-Beta-Lactamase VIM-2 in complex with (S)-N-(3-(2H-tetrazol-5-yl)phenyl)-3-mercapto-2-methylpropanamide

7CJL の概要
エントリーDOI10.2210/pdb7cjl/pdb
分子名称Beta-lactamase class B VIM-2, ZINC ION, FORMIC ACID, ... (5 entities in total)
機能のキーワードmetallo-beta-lactamase vim-2, vim-2, hydrolase
由来する生物種Pseudomonas aeruginosa
タンパク質・核酸の鎖数2
化学式量合計50193.18
構造登録者
Yan, Y.-H.,Chen, J.,Zhan, Z.,Yu, Z.-J.,Li, G.,Li, G.-B.,Guo, L.,Wu, Y. (登録日: 2020-07-11, 公開日: 2021-07-14, 最終更新日: 2023-11-29)
主引用文献Yan, Y.H.,Chen, J.,Zhan, Z.,Yu, Z.J.,Li, G.,Guo, L.,Li, G.B.,Wu, Y.,Zheng, Y.
Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-beta-lactamase inhibitors.
Rsc Adv, 10:31377-31384, 2020
Cited by
PubMed Abstract: β-Lactam antibiotic resistance mediated by metallo-β-lactamases (MBL) has threatened global public health. There are currently no available inhibitors of MBLs for clinical use. We previously reported the ruthenium-catalyzed meta-selective C-H nitration synthesis method, leading to some -mercaptopropanamide substituted aryl tetrazoles as new potent MBL inhibitors. Here, we described the structure-activity relationship of - and -mercaptopropanamide substituted aryl tetrazoles with clinically relevant MBLs. The resulting most potent compound 13a showed IC values of 0.044 μM, 0.396 μM and 0.71 μM against VIM-2, NDM-1 and IMP-1 MBL, respectively. Crystallographic analysis revealed that 13a chelated to active site zinc ions the thiol group and interacted with the catalytically important residues Asn233 and Tyr67, providing further structural information for the development of thiol based MBL inhibitors.
PubMed: 35520685
DOI: 10.1039/d0ra06405j
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.789 Å)
構造検証レポート
Validation report summary of 7cjl
検証レポート(詳細版)ダウンロードをダウンロード

227344

件を2024-11-13に公開中

PDB statisticsPDBj update infoContact PDBjnumon